• Yonghe Medical forecast net profit of at least RMB 70 million for H1 2026, up at least 150.9% from RMB 27.9 million a year earlier.
• Revenue expected to rise at least 10% versus H1 2025, supported by steady growth in core services.
• Hair transplantation revenue projected to increase at least 10%; medical hair care revenue seen up at least 15%.
• Gross margin expected to expand by at least 5 percentage points, driven by operating leverage and efficiency gains.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yonghe Medical Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260729-12259578), on July 28, 2026, and is solely responsible for the information contained therein.